Skip to main content
SpringerLink
Log in

Work-up polyneuropathisches Syndrom

Polyneuropathien — was ist diagnostisch sinnvoll?

  • Zertifizierte Fortbildung
  • Published:
DNP - Der Neurologe & Psychiater Aims and scope

Zusammenfassung

Der Begriff Polyneuropathie umfasst eine Vielzahl unterschiedlicher Erkrankungen und Erscheinungsformen. Diagnostik und ätiologische Zuordnung sind von enormer Bedeutung bei diesem Krankheitsbild mit hoher Prävalenz. Am Anfang stehen die Anamneseerhebung sowie die klinische Untersuchung. Zusatzuntersuchungen dienen dazu, eine weitere Einordnung des polyneuropathischen Syndroms vorzunehmen mit dem Ziel, eine Ursache zu finden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology 2016; 87(18):1892–8

    Article  PubMed  Google Scholar 

  2. Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol 2016; 31:5–20

    Article  PubMed  Google Scholar 

  3. Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: a systematic review. J. Neurol 2016; 263:1903–10

    Article  PubMed  Google Scholar 

  4. Morrison B, Chaudry V. Medication, toxic and vitamin-related neuropathy. Continuum 2012; 18:139–60

    PubMed  Google Scholar 

  5. Windebank AJ, Grisold W. Chemotherapy induced neuropathy. J Peripher Nerv Syst 2008; 13:27–46

    Article  CAS  PubMed  Google Scholar 

  6. Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K. The value of the Rydel-Seiffert tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. Diabet Med 2004; 21:563–7

    Article  CAS  PubMed  Google Scholar 

  7. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005; 64(2):199–207

    Article  CAS  PubMed  Google Scholar 

  8. Watson JC, Dyck PBJ. Peripheral neuropathy: A practical approach to diagnosis and symptom management. Mayo Clin Proc 2015; 90:940–51

    Article  PubMed  Google Scholar 

  9. Devigili G et al. The diagnostic criteria for small fiber neuropathy: from symptoms to neuropathology. Brain 2008; 131:1912–25

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bromberg M. An electrodiagnostic approach to the evaluation of peripheral neuropathies. Phys Med Rehabil Clin N Am 2013; 24:153–68

    Article  PubMed  Google Scholar 

  11. Bischoff C. Polyneuropathien. in: Bischoff C, Dengler R, Hopf HC (ed). EMG NLG. Thieme, Stuttgart 2014; p. 154–9

  12. Schulte-Mattler W. Conduction Velocity Distribution. In: Kimura J, editor. Neurophysiology of Peripheral Nerve Diseases. Amsterdam: Elsevier; 2006. p. 405–19

  13. Backonja MM, Walk D, Edwards RR, Sehgal N, Moeller-Bertram T, Wasan A, Irving G, Argoff C, Wallace M. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain 2009; 25:641–7

    Article  PubMed  Google Scholar 

  14. Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle Nerve 2013; 48:883–8

    Article  PubMed  Google Scholar 

  15. Stoll G, Bendszus M, Perez J, Pham M. Magnetic resonance imaging oft her peripheral nervous system. J Neurol 2009; 256:1043–51

    Article  PubMed  Google Scholar 

  16. Gasparotti R, Padua L, Briani C, Lauria G. New technologies for the assessment of neuropathies. Nature Reviews Neurology. 2017; 13:203–16

    Article  PubMed  Google Scholar 

  17. Gasparotti et al. Neuroimaging in the diagnosis of atypical polyradiculopolyneuropathies: report of three cases and review of the literature. J Neurol 262:1714–23

  18. Van den Bergh PY et al. European Federation of Neurological Science/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating neuropathy: report of a joint task force of the European Federation of Neurological Science and the Peripheral Nerve Society. Eur J Neurol 2010; 17:356–63

    Article  PubMed  Google Scholar 

  19. Ellegala DB et al. Characterization of genetically defined types of Charcot-Marie-Tooth neuropathies by using magnetic resonance imaging. J Neurosurg 2005; 102:242–5

    Article  PubMed  Google Scholar 

  20. Zaidman CM, Harms MB, Pestronk A. Ultrasound of inherited versus acquired demyelinating neuropathies. J Neurol 2013; 260:3115–21

    Article  PubMed  PubMed Central  Google Scholar 

  21. Grimm A et al. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for the differentiation of demyelinating inflammatory and hereditary neuropathies. Clin Neurophysiol 2016; 127:2618–24

    Article  PubMed  Google Scholar 

  22. Dyck PJ, Katz, KM, Karres, JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43:817–24

    Article  CAS  PubMed  Google Scholar 

  23. Bulton AJ, Vinik AL, Arezzo J et al. Diabetic neuropathies a statement by the American Diabetes Association. Diabetes Care 2005; 28:956–62

    Article  Google Scholar 

  24. Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 2006; 63(8):1075–9

    Article  PubMed  Google Scholar 

  25. Hanewinckel R, Drenthen J, Ligthart S, Dehghan A, Franco OH, Hofman A et al. Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study. J Neurol Neurosurg Psychiatr. 2016; 87(12):1336–42

    Article  Google Scholar 

  26. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001; 24:1448–53

    Article  CAS  PubMed  Google Scholar 

  27. Summer CJ, Sheth S, Griffin JW, Cornblath DR, Podydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60:108–11

    Article  Google Scholar 

  28. Saperstein DS, Wolfe GJ, Gronseth GS et al. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol 2003; 60:1296–301

    Article  PubMed  Google Scholar 

  29. Smith AG, Singleton JR. The diagnostic yield of a standardized approach to idiopathic sensory-predominant polyneuropathy. Arch Intern Med. 2004; 164:1296–1301

    Google Scholar 

  30. Callaghan BC, Price RS, Feldman EL. Diagnostic and therapeutic advances: distal symmetric polyneuropathy. JAMA 2015; 314:2172–81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kelly JJ, Kyle RA, O’Brien PC, Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981; 31:1480–3

    Article  PubMed  Google Scholar 

  32. Kahn SN, Bira M. Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum. Clin Chem 1988; 34:1633–5

    PubMed  CAS  Google Scholar 

  33. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn PJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2005; 615–20

    Google Scholar 

  34. Chaudry HM, Mauermann ML, Rajkumas SV. Monoclonal gammopathy-associated peripheral neuropathy: Diagnosis and management. Mayo Clin Proc 2017; 92:838–50

    Article  Google Scholar 

  35. Braathen GJ, Sand JC, Lobato A, Hoyer H, Russel MB. Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol 2011; 18:39–48

    Article  CAS  PubMed  Google Scholar 

  36. England JD, Groseth GS, Franklin G et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory genetic testing. Neurology 2009; 72:185–92

    Article  CAS  PubMed  Google Scholar 

  37. Gallagher G, Rabquer A, Kerber K, Cabalek B, Callaghan B. Value of thyroid and rheumatologic studies in the evaluation of peripheral neuropathy. Neurology Clinical practice 2013; 3:90–8

    Article  PubMed  PubMed Central  Google Scholar 

  38. Van den Bergh PYK, Haddenb RDM, Bouchec P, Cornblathd DR, Hahne A, Illaf I, Koskig CL, J. Légerh JM, Nobile-Orazioi E, Pollardj J, Sommerk C, van Doornl PA, van Schaik IN. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision Members of the Task Force. Eur J Neurol 2010; 17:356–63

    Article  PubMed  Google Scholar 

  39. Luria G. et al. European Federation of Neurological Science/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. J Periph Nerv Syst 2010; 15:79–92

    Article  Google Scholar 

  40. Sachedina S, Toth C. Progression in idiopathic, diabetic, paraproteinemic, alcoholic and B12 deficiency neuropathy. J Periph Nerv Syst 2013; 18:247–55

    Article  Google Scholar 

  41. Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 1999; 56:540–7

    Article  CAS  PubMed  Google Scholar 

  42. Notermans NC, Wokke HJ, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG. Chronic idiopathic axonal neuropathy: a five year follow-up. J Neurol Neurosurg Psychiat 1994; 57:1525–7

    Article  CAS  PubMed  Google Scholar 

  43. Euerlings M, van den Berg LH, Wokke JH, Franssen H, Vrancken AF, Notermans NC. Increase of sural nerve T cells in progressive axonal neuropathy and monoclonal gammopathy. Neurology 2003; 61:707–9

    Article  Google Scholar 

  44. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014 Sep 19;(9):CD002063. doi: 10.1002/14651858.CD002063.pub6.

    Google Scholar 

  45. Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017 Jan 13;1:CD010369. doi: 10.1002/14651858.CD010369.pub2

    Google Scholar 

  46. Finsterer J, Wanschitz J, Quasthoff S, Iglseder S, Löscher W, Grisold W. Causally treatable, hereditary neuropathies in Fabry’s disease, transthyretin-related familial amyloidosis, and Pompe’s disease. Acta Neurol Scand 2017; 136(6):558–69

    Article  CAS  PubMed  Google Scholar 

  47. Coelho T, Maia LF, Martins da Silva A, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 2012; 79:785–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Berk JL, Suhr OB, Obici L et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA 2013; 310:2658–67

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Lunn MP, Nobile-Orazio E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev. 2016 Oct 4;10:CD002827

    Google Scholar 

  50. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane. Database Syst Rev 2012; 6:CD007543

    PubMed Central  Google Scholar 

  51. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393–403

    Article  CAS  PubMed  Google Scholar 

  52. Dworkin RH, O’Connor AB, Audette J et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85(suppl):S3–S14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17:1113–e88

    Article  CAS  PubMed  Google Scholar 

  54. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev. 2012; 7:CD008943

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Burgstr. 7, 80331, München, Deutschland

    Christian Bischoff (Neurologische Gemeinschaftspraxis am Marienplatz)

Authors
  1. Christian Bischoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Bischoff.

Additional information

Interessenkonflikt

Der Autor erklärt, dass er sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließ und dass keine potenziellen Interessenkonflikte vorliegen.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.

Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bischoff, C. Polyneuropathien — was ist diagnostisch sinnvoll?. DNP 19, 55–63 (2018). https://doi.org/10.1007/s15202-018-1879-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15202-018-1879-8

Search

Navigation